Amarin is engaged in the development of innovative pharmaceutical products using its proprietary topical and transdermal drug delivery technologies and know-how. More
Ferndale Laboratories is dedicated to discovering, developing and delivering unique, branded pharmaceuticals that provide therapeutic dermatology solutions to the under-served medical specialties. More
The Pierre Fabre Group, the second-largest independent laboratory in France, employs about 9,300 people and achieved sales of 1.47 billion euros in 2004. More
CollaGenex is developing dermatological applications of its proprietary IMPACS™ technology. Oracea™ (doxyxcycline, USP) 40 mg* was approved by the FDA on May 26, 2006. More
SkinMedica's Mission is to build a specialty skin care pharmaceutical company by developing, acquiring and commercializing patented cosmeceutical and pharmaceutical products. More
All rights reserved. Terms and Conditions | Contact us
